ArticleGynecologic oncology reports2026

Long lasting response to the combination of Avutometinib and Defactinib after progression on Binimetinib in a patient with recurrent low grade serous ovarian carcinoma - A case report.

Victoria M Ettorre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.